GSK Competitors & Alternatives
Compare GlaxoSmithKline PLC ADR with similar stocks in the same industry
Drug Manufacturers - General
GSK
Main Stock$50.67
Tradestie Score
59
Market Cap
$91.59B
P/E Ratio
13.7
Revenue Growth
0.0%
Analyst Upside
+11.8%
Top Competitors
16 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVS
Novartis AG
|
$147.08
|
$254.99B | 21.6 | 61 | Compare |
|
MRK
Merck & Co., Inc.
|
$113.87
|
$225.13B | 32.5 | 60 | Compare |
|
AMGN
Amgen Inc
|
$337.60
|
$160.70B | 23.8 | 53 | Compare |
|
PFE
Pfizer Inc.
|
$25.21
|
$154.70B | 19.8 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$123.76
|
$137.92B | 17.1 | 58 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$42.38
|
$121.27B | 18.5 | 56 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$54.00
|
$96.54B | 15.5 | 46 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$196.58
|
$22.61B | 21.4 | 58 | Compare |
|
GRFS
Grifois, S.A.
|
$7.40
|
$6.78B | 10.5 | 56 | Compare |
|
OGN
Organon & Co.
|
$13.43
|
$2.86B | 14.4 | 59 | Compare |
More GSK Analysis
Data updated: Jun 21, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
16 stocks in this industry